GALMED PHARMACEUTICALS LTD. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b958b57d-442b-4941-b62d-4cc0edcf5e7b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-30.2M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-038205 |
| FY 2019 | $-22.4M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032166 |
| FY 2018 | $-10.7M | 2018-01-01 – 2018-12-31 | evidence 0001104659-20-032166 |
| FY 2017 | $-12.4M | 2017-01-01 – 2017-12-31 | evidence 0001104659-20-032166 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GALMED PHARMACEUTICALS LTD. — all facts · Revenue · Net Income